Author's correction Open Access
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2024.29.8.240222c
Like 0
This item has no PDF Download
-
Authors’ correction for Euro Surveill. 2024;29(3)
-
View Affiliations Hide AffiliationsCorrespondence:Eurosurveillance editorial teameurosurveillance ecdc.europa.eu
-
View Citation Hide Citation
Citation style for this article: . Authors’ correction for Euro Surveill. 2024;29(3). Euro Surveill. 2024;29(8):pii=240222c. https://doi.org/10.2807/1560-7917.ES.2024.29.8.240222c
- Previous Article
- Table of Contents
- Next Article
There is no abstract available.
© 
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Closure
This is a corrected article applying to the following content:
Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥ 60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023
Full text loading...
Comment moderation successfully completed